UCSF to develop first AI monitoring platform for clinical care
CALIFORNIA, UNITED STATES — The University of California San Francisco (UCSF) Division of Clinical Informatics and Digital Transformation (DoC-IT) and UCSF Health were recently awarded a $5 million donation to help develop a new AI-monitoring platform for clinical care.
The donation, given by Silver Lake Chairman Kenneth Hao and his wife Kathy Hao, will fund the creation of the Impact Monitoring Platform for AI in Clinical Care (IMPACC), a pioneering real-time, continuous, and automated AI monitoring platform.
Bridging the gap in AI monitoring for healthcare
IMPACC aims to address the critical need for ongoing assessment of AI technologies in clinical settings.
DoC-IT Chief Julia Adler-Milstein and USCF Health Chief Health AI Officer Sara Murray will lead this groundbreaking initiative.
Adler-Milstein emphasized the significance of the donation, stating, “This philanthropic gift is transformative in many ways. It comes at a critical juncture as the healthcare industry more broadly integrates AI into clinical practice.”
Ensuring safety and efficacy of AI tools
Currently, the healthcare sector lacks established protocols for continuous AI monitoring, posing risks of undetected adverse outcomes.
IMPACC will transition from periodic, manual monitoring to real-time, continuous, and automated surveillance. This shift will enable prompt identification of issues in AI performance, ensuring both the effectiveness and safety of AI tools in clinical use.
Murray highlighted the platform’s potential impact, saying, “By building IMPACC, we will take a major leap forward in how we analyze AI’s performance in healthcare.”
“As we deploy new AI technologies, this novel, scalable platform will provide our health system with direct and actionable insights into ongoing performance, ensuring not only the effectiveness of these new tools but also safety across the system and benefit for patients,” she added.
Real-world deployment and patient transparency
IMPACC will initially be piloted at UCSF Health, focusing on current AI tools. The platform will monitor performance and impact on clinical outcomes, informing healthcare leaders on decisions about scaling, refining, or discontinuing AI tools.
Additionally, a dashboard will be developed to allow patients to track AI usage in their care.
UCSF Health President and CEO Suresh Gunasekaran said that this will be the first collaboration between UCSF and UCSF Health on AI monitoring.
“Together, we are uniquely positioned to create the first effective model platform across health systems in the United States that will offer real-time visibility into AI tool performance and clinical impact.”
The development of IMPACC requires a blend of technical and social sciences expertise, making UCSF and UCSF Health ideally suited for this innovative project.
The Haos’ visionary support enables UCSF to pursue vital research and its translational applications, setting a new standard for AI monitoring in healthcare.
